SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
BJ's Wholesale Club disclosed settlement of litigation related to credit card interchange fees in which the Company was a plaintiff, resulting in a one-time pre-tax benefit of approximately $240 million. This is a material litigation settlement that will significantly impact Q3 fiscal 2026 results and is disclosed under Item 8.01 (Other Events), consistent with the material_litigation classification for material settlements.
View raw filing on EDGAR →The filing discloses a Revised 2026 Annual Budget with aggregate budgeted expenses of $19,500,000, with the revision "primarily due to unanticipated legal costs related to litigation." While the specific litigation details are not elaborated, the material increase in budgeted expenses attributable to litigation costs constitutes a disclosure of a material legal event that would affect a reasonable investor's assessment of the Trust's financial obligations and operational costs. The litigation itself is the driver of the budget revision and thus the salient event.
View raw filing on EDGAR →AMC Global Media settled a material breach-of-contract litigation with Robert Kirkman, Glen Mazzara, Gale Anne Hurd, and other producers for $120 million total ($85 million cash by September 18, 2026, plus $35 million by January 31, 2027), with dismissal with prejudice and mutual releases. The company took an $85 million charge in Q3 2026 related to this settlement.
View raw filing on EDGAR →The filing discloses that EGH was added as a defendant on March 5, 2026 in a declaratory judgment claim brought by NEC Fund entities against Hecate Holdings, Hecate Energy Group, Repsol Renewables, and EGH in Delaware Court of Chancery. On August 27, 2026, the parties entered into a mutual release and settlement agreement to resolve the claims and intend to file a motion to dismiss. This settlement of material litigation involving the registrant and its parent company is a significant event affecting the business combination timeline and lender relationships, making it material to investors evaluating the transaction.
View raw filing on EDGAR →The disclosure reports a favorable Federal Circuit Court of Appeals decision in Exelixis, Inc. v. MSN Laboratories Private Limited affirming that three Exelixis patents (11,091,439, 11,091,440, and 11,098,015) are not invalid, which establishes a January 15, 2030 earliest effective date for FDA approval of MSN's generic ANDA. This patent litigation outcome materially affects the timing and competitive landscape for a generic competitor's market entry and is therefore a material litigation event. The filing also references ongoing separate litigation involving U.S. Patent No. 12,128,039 with trial scheduled for November 2026, further underscoring the litigation context.
View raw filing on EDGAR →A putative securities class action complaint (Labed v. Innventure, Inc., Case No. 1:26-cv-07377) was filed August 28, 2026 in the U.S. District Court for the Southern District of New York against the Company and certain executive officers, alleging materially false and misleading statements under Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5, and seeking unspecified compensatory damages.
View raw filing on EDGAR →This Item 8.01 discloses settlement of a putative stockholder derivative and class action lawsuit alleging breaches of fiduciary duty by JBS (majority stockholder) and company directors regarding a Charter Amendment and Tax Sharing Agreement. The settlement requires a $31 million cash payment from JBS Defendants to the Company, subject to Delaware Court of Chancery approval. This is a material litigation settlement that would affect a reasonable investor's assessment of the company's legal exposure and financial position.
View raw filing on EDGAR →The 6-K discloses a material litigation event: a statement of claim filed on August 24, 2026, in the Central District Court of Israel against Silynxcom Ltd., its U.S. subsidiary, and two named executives (CEO Nir Klein and VP Gal Nir Klein). The Plaintiffs allege wrongful control, invalid proxies, and dilution of equity interests, seeking NIS 16.9 million in damages or transfer of 650,694 shares per plaintiff. This is a material legal proceeding involving the Company's leadership and substantial claimed damages that would affect a reasonable investor's assessment of governance and financial risk.
View raw filing on EDGAR →KKR disclosed settlement of a civil antitrust complaint filed by the Department of Justice's Antitrust Division regarding HSR premerger notification violations in 2021–2022 transactions. The settlement involves a $250 million payment by a KKR subsidiary and full release from all related claims and investigations.
View raw filing on EDGAR →The Trust filed a complaint in Massachusetts Superior Court against Anton Melchionda and Onyx Partners Ltd., LLC alleging fraud, unfair and deceptive conduct, and interference with business relationships related to a failed ~$947 million real estate transaction. The complaint alleges defendants misrepresented their funding capacity, induced the Trust into a purchase agreement, then engaged in a campaign to cloud title and block alternative sales, causing over $150 million in damages. This is material litigation involving a substantial financial claim directly affecting the Trust's core asset liquidation mission.
View raw filing on EDGAR →The disclosure centers on a material contractual dispute over a $1.0 million earnest-money deposit for a $20.0 million real estate acquisition. The Seller asserted default on August 18, 2026, claiming entitlement to retain the Deposit, and the Company disputes this and is "pursuing their available contractual, legal and equitable rights and remedies, which may include litigation." The dispute threatens to delay or prevent the acquisition, could require impairment of the Deposit, and may result in legal expenses and adverse effects on liquidity and financial condition—all material consequences to a reasonable investor.
View raw filing on EDGAR →A jury found Cytek infringed one patent claim under the doctrine of equivalents in a patent infringement action brought by Beckman Coulter and awarded $56.11 million in damages ($20 million in lost profits and $36.11 million in royalties), although Cytek prevailed on three of four claims. The material damages award and ongoing litigation risk from post-trial motions and potential appeal materially affect the company's financial condition and legal exposure.
View raw filing on EDGAR →The 6-K discloses three putative securities class actions filed against Linkers Industries in New York state court alleging violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 related to alleged market manipulation in IPO offerings. The Company has been served in at least one action (Morales Action) and intends to defend vigorously. This is material litigation that would affect a reasonable investor's assessment of legal and financial risk.
View raw filing on EDGAR →Zillow announced a resolution with the Federal Trade Commission and five state attorneys general regarding its multifamily rental listings syndication agreement with Redfin. The settlement, documented as a stipulated final order for equitable relief filed in federal court, allows the partnership to continue through 2030 while adding new standalone product offerings in 2027, removing legal uncertainty and affecting Zillow's rental marketplace strategy.
View raw filing on EDGAR →This disclosure centers on a series of material court orders in multiple related pipeline litigation cases involving Sable Offshore Corp. The Company faces a $1.449 million penalty for violating a consent decree, declaratory judgments affecting its pipeline operations, and ongoing legal challenges to its restart of the Santa Ynez Pipeline System. These outcomes directly impact the Company's ability to operate its core business asset and represent material litigation developments that would affect a reasonable investor's assessment of the registrant's legal and operational risks.
View raw filing on EDGAR →Abbott announced settlement of material litigation involving specialty formulas for preterm infants, resolving the Gill case (which had a $495 million jury verdict in July 2024) and claims on behalf of approximately 2,000 other individuals for an aggregate settlement amount of approximately $670 million, with approximately 1,700 pending lawsuits involving approximately 12,700 individual infants remaining.
View raw filing on EDGAR →Vale discloses that 19 additional municipalities have joined a "Definitive Agreement for the compensation and reparation of damages arising from the collapse of the Fundão dam" in Mariana, Minas Gerais (which occurred November 5, 2015). This represents a material settlement of a major environmental and legal liability affecting 45 of 49 eligible municipalities. The agreement involves waiver of lawsuits and judicial proceedings in Brazil and abroad, with significant financial obligations (lump-sum payments plus installment schedules). This is a material litigation settlement that would affect a reasonable investor's assessment of Vale's contingent liabilities and legal exposure.
View raw filing on EDGAR →The filing discloses material shareholder litigation challenging the Merger Agreement and proxy disclosures. Three complaints were filed on August 6 and August 17, 2026 (McDaniels, Clark, and Drulias) alleging materially false and misleading statements in the proxy statement and seeking injunctive relief to prevent the merger or damages. Additionally, Crinetics received multiple demand letters from shareholders requesting corrective disclosures. While the company denies the allegations, the disclosure of pending litigation that could enjoin a $10 billion merger transaction is material to investors evaluating the merger.
View raw filing on EDGAR →Aurinia announced a settlement agreement with Teva resolving patent infringement litigation over voclosporin generic entry. The settlement stipulates validity and enforceability of two key patents expiring in December 2037 and grants Aurinia market exclusivity until December 7, 2036. This is a material litigation settlement that directly affects the company's ability to protect its lead commercial product (LUPKYNIS/voclosporin) from generic competition, a core business asset for a biopharmaceutical company.
View raw filing on EDGAR →The filing discloses a derivative lawsuit filed on August 14, 2026, against GPHC and certain officers and directors, asserting claims for federal securities law violations, breach of fiduciary duty, aiding and abetting, waste of corporate assets, and unjust enrichment. This is material litigation that would affect a reasonable investor's assessment of the company's legal and financial exposure, particularly given the serious nature of the allegations and the involvement of current and former executives.
View raw filing on EDGAR →The filing discloses settlement of material litigation with Puritan Partners LLC that had been pending since November 2023 and "hindered our ability to raise capital and pursue strategic opportunities." The settlement involves exchange of existing debt instruments for new $2.35 million senior secured convertible notes maturing in February 2028. This is a material litigation settlement that removes a significant constraint on the company's operations and capital access, making it material to investors.
View raw filing on EDGAR →The disclosure announces the voluntary dismissal with prejudice of a lawsuit filed by James C. Justice, II and related parties against Carter Bankshares and Carter Bank & Trust in West Virginia state court. While the dismissal itself is favorable to the Company, the filing of material litigation by a significant party (Justice, a prominent West Virginia figure with substantial business interests) and its resolution is a material event that would affect a reasonable investor's assessment of the Company's legal and operational risks. The dismissal with prejudice is the resolution of previously disclosed litigation.
View raw filing on EDGAR →The Company and Carmell Regen settled litigation with Puritan, with parties agreeing to file a stipulation dismissing the case. The settlement is documented in a Settlement Agreement and involves material financial and operational consequences.
View raw filing on EDGAR →The filing discloses three stockholder lawsuits (Garfield, O'Connor, and Turner) challenging the Merger on grounds of materially false or misleading proxy disclosures, conflicts of interest, and deficient merger process disclosures. The Company also received demand letters alleging disclosure deficiencies. Although the Company denies merit and believes the allegations are without merit, it voluntarily supplemented proxy disclosures "solely to avoid the nuisance, risks, costs, and uncertainties inherent in disputes" and to prevent delay or adverse effects on the Merger. This is material litigation related to a pending M&A transaction that could affect shareholder voting and deal completion.
View raw filing on EDGAR →The 6-K discloses a securities class action complaint filed on July 23, 2026, in New York Supreme Court naming Basel Medical Group Ltd and more than 30 other publicly traded companies as defendants, with service on the Company's process agent on August 5, 2026. This is a material litigation disclosure that would affect a reasonable investor's assessment of the Company's legal and financial exposure, even though the Company states it is unable to predict the outcome at this early stage.
View raw filing on EDGAR →This disclosure reports the preliminary court approval of a settlement of consolidated stockholder derivative litigation against Evolv's board and management, resolving claims arising from improper sales practices, revenue recognition errors, and false marketing claims regarding the company's core technology. The settlement includes mandatory corporate governance reforms and was preceded by FTC and SEC investigations, an accounting restatement, and delayed financial results—all material events that affected investor confidence. Although no monetary payment is required from the company, the settlement's approval by the federal court and the binding governance reforms constitute a material resolution of significant litigation that directly addresses the company's past disclosure and internal control failures.
View raw filing on EDGAR →This disclosure reports settlement of material shareholder litigation challenging Illumina's $8 billion GRAIL acquisition. The settlement involves mutual releases and dismissal with prejudice as to the named plaintiffs (Icahn Partners LP, et al.) in Delaware Court of Chancery case C.A. No. 2023-1045-PAF, pending court approval at a November 2, 2026 hearing. The underlying claims alleged breach of fiduciary duties related to the GRAIL transaction, regulatory scrutiny, and inadequate disclosures in 2023 proxy filings—matters material to investors assessing the company's governance and acquisition decision-making.
View raw filing on EDGAR →The filing discloses preliminary court approval of a settlement of consolidated shareholder derivative lawsuits against CorMedix and its officers/directors. The underlying claims allege breach of fiduciary duties related to false/misleading statements about manufacturing deficiencies that delayed FDA approval of DefenCath, resulting in a securities fraud class action and significant harm to the company. The settlement requires implementation of corporate governance reforms over 3.5 years, with potential attorneys' fees up to $3.9 million. This is a material litigation settlement with substantial corporate governance consequences.
View raw filing on EDGAR →iRhythm Technologies and Baxter settled patent litigation involving mutual accusations of patent infringement with a $50 million settlement payment and cross-licenses, resolving all outstanding patent disputes and including covenants not to sue for six years.
View raw filing on EDGAR →The disclosure describes an active investigation by the FDA and Minnesota Department of Health into a salmonella outbreak affecting Chipotle's supply chain across multiple states. While framed as a health and safety matter, this constitutes a material regulatory investigation that could result in enforcement action, liability, or reputational harm. The company's proactive ingredient removal and cooperation with authorities, combined with the explicit statement that guidance did not include financial impacts due to "uncertain nature of any possible outcomes," signals material regulatory risk requiring investor disclosure.
View raw filing on EDGAR →This disclosure reports the final resolution of a material arbitration dispute initiated by NorthStar Earth & Space against Legacy Spire, with the arbitral tribunal issuing a Final Award of approximately $12.4 million in favor of Spire Global on July 31, 2026. The tribunal dismissed all of NorthStar's claims (including fraud allegations) and granted Legacy Spire's counterclaims for the promissory note, injunction costs, and arbitration costs. This material litigation settlement outcome would significantly affect a reasonable investor's assessment of the company's legal exposure and financial position.
View raw filing on EDGAR →On August 3, 2026, XTL Biopharmaceuticals was served with a shareholder derivative motion in Israeli court alleging that the controlling shareholder and current/former directors breached fiduciary duties in connection with the 2024 acquisition of The Social Proxy Ltd., including alleged failures to fund the subsidiary, conflicts of interest, delayed disclosure, and financial irregularities. The petitioner seeks court authorization to file a derivative claim, monetary compensation estimated at approximately NIS 100 million, disgorgement, forensic accounting, and attorneys' fees. This is a material litigation disclosure involving substantial alleged damages and governance failures.
View raw filing on EDGAR →The Company filed a lawsuit in Delaware Court of Chancery against Kuva Labs and its subsidiary alleging breach of a Merger Agreement dated March 6, 2026, and seeking damages for stockholder benefits.
View raw filing on EDGAR →The 6-K discloses material litigation commenced by J.B.D Innovation Ltd. and Victor Tshuva & Co. in the Haifa District Court on August 2, 2026, challenging the Company's private placement of 1,000,000 ordinary shares and warrants. The Court issued an interim ex parte order temporarily prohibiting the Company from advancing the Private Placement or effecting changes to its capital structure, with a hearing scheduled for August 12, 2026. This litigation directly blocks a material capital-raising transaction and creates substantial uncertainty regarding the Company's ability to complete the Private Placement, making it material to investors.
View raw filing on EDGAR →The filing discloses settlement of litigation commenced by former CFO Doug Durst in connection with his employment termination. The Company paid $247,500 in cash to Durst and $55,890 to his affiliate Chase Innovations, plus issued a warrant for 57,600 shares at $4.11 exercise price. This represents a material settlement of an employment-related dispute that would affect investor assessment of the registrant's legal and financial position.
View raw filing on EDGAR →TotalEnergies announced its decision to appeal a June 25, 2026 judgment rendered by the Paris Judicial Court in a duty of vigilance climate case brought by certain associations under French law, representing a material legal development affecting the company's regulatory and legal exposure.
View raw filing on EDGAR →Teads filed a lawsuit against Google LLC and Alphabet Inc. in the U.S. District Court for the Southern District of New York on August 3, 2026, alleging unlawful anticompetitive practices in digital advertising technology markets, including monopolization, illegal tying, and deceptive practices spanning over a decade. The complaint asserts seven counts under Sherman Act and state law, seeking financial damages and other remedies.
View raw filing on EDGAR →The Seoul Central District Court issued a judgment against Franklin Technology Inc. (a subsidiary of Franklin Wireless Corp.) ordering payment of approximately $3.67 million in damages plus interest in a commercial contract dispute with Partron Co., Ltd. This is a material litigation settlement/judgment that would affect a reasonable investor's assessment of the company's financial obligations and legal exposure.
View raw filing on EDGAR →The filing discloses preliminary court approval of a settlement of consolidated stockholder derivative litigation (In re Latch Inc. Derivative Litigation, Case No. 1:23-cv-01273-JGK) alleging breaches of fiduciary duties and false statements regarding financial metrics. The settlement includes a $450,000 fee and expense payment to plaintiffs' counsel and comprehensive corporate governance reforms to be implemented for 3.5 years. This is a material litigation settlement that would affect a reasonable investor's assessment of the company's governance and legal exposure.
View raw filing on EDGAR →AnaptysBio disclosed material litigation against Tesaro and GlaxoSmithKline regarding alleged material breach of a Collaboration and Exclusive License Agreement and tortious interference. The filing provides substantive updates on trial completion (July 14-17, 2026) and a court-approved post-trial briefing schedule, indicating this is an ongoing material dispute with significant financial and operational implications for the Company's collaboration arrangements.
View raw filing on EDGAR →The filing discloses a material litigation development: dismissal of two major antitrust lawsuits against Westlake in the Netherlands and Germany, including one by Shell Chemical Europe alleging approximately €1,025 million in damages. Although the dismissals are favorable to the Company, they remain subject to appeal and twelve related lawsuits are still pending, making this a significant material litigation event affecting investor assessment of the Company's legal exposure and contingent liabilities.
View raw filing on EDGAR →The 6-K discloses settlement of a material lawsuit filed by shareholders against the Company and Co-CEO Satoshi Kobayashi in Tokyo District Court in December 2023. The Plaintiffs originally sought USD 2.925 million in damages for alleged breach of obligation related to the IPO. On July 17, 2026, a judicial settlement was reached with a settlement payment of JPY 20 million (approximately USD 122,000) completed on July 27, 2026, and withdrawal of provisional attachments on the Company's bank accounts. This settlement of material litigation affecting a named executive and the Company's operations is material to investors.
View raw filing on EDGAR →Judge Denise Cote of the U.S. District Court for the Southern District of New York entered an Opinion and Order awarding $719 million in disgorgement of unjust profits plus attorney's fees and costs to Skillz Platform Inc. (Firy's subsidiary) in a false advertising lawsuit against Papaya Gaming under the Lanham Act and New York General Business Law. This is a material litigation settlement/judgment that materially affects the registrant's financial position and would significantly influence a reasonable investor's assessment of the company.
View raw filing on EDGAR →Johnson & Johnson announced a comprehensive settlement agreement for ovarian talc litigation with a $5.5 billion commitment, resolving approximately 76,000 remaining claims. This represents a material settlement of long-standing product liability litigation that would significantly affect investor assessment of the company's financial obligations and legal exposure. The settlement follows a favorable MDL court ruling on causation but constitutes a major resolution of a 15-year litigation matter.
View raw filing on EDGAR →The Company disclosed an adverse arbitration decision rendered on July 24, 2026, dismissing its claims against 3D Medicines and imposing approximately $1.0 million in legal fees and costs on the Company. This outcome materially affects the Company's financial position and its rights under the exclusive license agreement for galinpepimut-S, with $191.5 million in potential future milestone payments at stake.
View raw filing on EDGAR →Vulcan disclosed a NAFTA tribunal decision in a long-standing arbitration against Mexico over alleged violations related to the company's aggregates reserves and quarrying operations. Although the tribunal found Mexico violated NAFTA, the monetary damages award was "negligible." This is a material litigation/arbitration outcome affecting a significant international business dispute that has been pending since 2018, warranting disclosure under Item 8.01 (Other Events) as a material legal matter.
View raw filing on EDGAR →The filing discloses two stockholder lawsuits filed in New York Supreme Court (O'Toole v. GBTG and Lawrence v. GBTG) alleging omissions and misstatements in the Definitive Proxy Statement related to the pending merger. The complaints seek injunctions against the stockholder vote and merger consummation, rescission, and damages. Although the company denies liability and voluntarily supplemented disclosures to moot claims, the existence of active litigation seeking to enjoin a material transaction qualifies as material litigation under Item 8.01.
View raw filing on EDGAR →A jury issued an advisory verdict awarding $604 million in compensatory damages against C.H. Robinson in a trucking accident lawsuit. This is a material litigation event involving a substantial financial exposure that would affect a reasonable investor's assessment of the company's financial condition and contingent liabilities, even though the verdict remains subject to post-trial proceedings and appeal.
View raw filing on EDGAR →The 6-K discloses two material litigation matters: (1) a shareholder derivative discovery motion filed July 16, 2026 by Gad Libman seeking court-ordered inspection of company documents related to recent public disclosures, with a hearing scheduled for December 15, 2026; and (2) a class action certification motion filed July 21, 2026 by Hadar Shamai alleging misleading statements regarding the residential proxy business, claiming damages up to NIS 120 million and seeking certification on behalf of shareholders who purchased between March 29, 2022 and July 2, 2026. Both matters involve allegations of securities law violations and would materially affect a reasonable investor's assessment of the registrant's legal and financial exposure.
View raw filing on EDGAR →The Company settled material litigation filed by the Jeffrey L. Feinberg Personal Trust against ONAR LLC alleging breach of contract and unjust enrichment on a $1.5 million Senior Secured Promissory Note. Under the settlement agreement executed July 16, 2026, the Company is obligated to pay $1.5 million principal plus 18% annual interest through February 2030, with dismissal and mutual release of claims.
View raw filing on EDGAR →